Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.07B 1.04B 912M 841M 777M 1.47B 99.45B 1.5B 10.05B 3.95B 48.99B 3.91B 3.83B 168B P/E 2026 *
16x
P/E 2027 * 13.7x
Enterprise Value 7.59B 1.12B 979M 903M 834M 1.58B 107B 1.61B 10.79B 4.24B 52.59B 4.2B 4.11B 181B EV / Sales 2026 *
2.01x
EV / Sales 2027 * 1.74x
Free-Float
51.96%
Yield 2026 *
1.93%
Yield 2027 * 3.1%
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-27 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
25-10-29 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
25-10-24 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-14 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
25-06-13 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
25-04-30 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
25-04-29 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
25-04-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend on A Shares for the Year 2024, Payable on 21 May 2025 CI
1 day+1.57%
1 week-1.02%
Current month+7.90%
1 month+0.78%
3 months-15.20%
6 months-21.76%
Current year-17.05%
1 week 15.21
Extreme 15.21
16.19
1 month 13.91
Extreme 13.91
16.19
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
24.03
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
31.63
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-29
Director of Finance/CFO 51 2022-04-27
Corporate Officer/Principal 45 2020-10-26
Director TitleAgeSince
Chairman 63 2008-05-11
Director/Board Member 53 2019-12-24
Director/Board Member 51 2020-01-09
Date Insider Type Main position Quantity % Market Cap.
06-15Buy

Chief Executive Officer

500,000 0.1535%
23-05-23Buy 3,000 0.0009%
23-05-22Buy 1,000 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.57%-1.02%-19.74%-13.69% 1.04B
+0.64%+1.02%-52.42%-55.61% 31.68B
+0.81%-0.72%+65.03%+144.53% 12.4B
+0.77%-6.73%-18.89%-1.99% 3.59B
+1.10%-3.46%-7.10%+26.18% 3.07B
0.00%-1.06%+53.40%+26.61% 1.96B
+0.16%+0.50%-28.82%+21.31% 1.67B
-0.96%-3.58%+2.99%+124.74% 1.3B
-0.42%+0.28%-8.51%-18.67% 943M
+1.33%-2.56%-18.03%-48.82% 917M
Average +0.50%-2.31%-3.21%+20.46% 5.86B
Weighted average by Cap. +0.65%-0.48%-15.85%+4.73%

Financials

2026 *2027 *
Net sales 3.77B 556M 486M 448M 414M 786M 53B 799M 5.36B 2.1B 26.11B 2.09B 2.04B 89.76B 4.26B 628M 549M 507M 468M 888M 59.91B 903M 6.06B 2.38B 29.51B 2.36B 2.31B 101B
Net income 441M 65.05M 56.9M 52.48M 48.47M 91.97M 6.2B 93.52M 627M 246M 3.06B 244M 239M 10.51B 527M 77.79M 68.04M 62.76M 57.96M 110M 7.42B 112M 750M 294M 3.65B 292M 286M 12.56B
Net Debt 519M 76.6M 67M 61.8M 57.08M 108M 7.31B 110M 738M 290M 3.6B 288M 281M 12.37B 337M 49.7M 43.47M 40.1M 37.03M 70.27M 4.74B 71.45M 479M 188M 2.34B 187M 183M 8.03B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
26-07-10 CN¥15.57 +1.57% 3,680,700
26-07-09 CN¥15.33 -2.97% 4,278,400
26-07-08 CN¥15.80 +0.45% 4,444,805
26-07-07 CN¥15.73 -1.63% 3,576,300
26-07-06 CN¥15.99 +1.65% 4,769,606
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.57CNY
Average target price
20.41CNY
Spread / Average Target
+31.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock